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portant in the fetal and neonatal periods, and finally, EP studies in human
disease.
The monograph tells us that EP is the principle hormone which regu-
lates erythropoiesis. It is a glycoprotein with a molecular weight of 60,000
to 70,000. The kidney produces either the hormone itself or an enzyme
activating the plasma substrate. The site of EP production in the kidney
is unknown, but the greatest concentration is separated in a "light mito-
chondrial" fraction. EP acts by causing a committed but undifferentiated
cell to differentiate into an erythroblast, and may also have a role in caus-
ing maturation of erythroblasts. In bone marrow culture, EP acts sequen-
tially to increase synthesis of RNA, then DNA, and to increase incorpora-
tion of iron into red cells and into heme. On a clinical level, anemias due
to hemorrhage, hemolysis, and vitamin deficiencies are associated with
elevated EP, whereas the anemias of uremia, protein starvation, and
chronic inflammation are not. Administration of EP, when it becomes
available, should benefit at least the latter conditions. Polycythemias sec-
ondary to hypoxia and tumors may be associated with elevated EP levels,
whereas primary polycythemias are not.
This information and much more has been acquired largely by using
bioassay techniques such as injecting plasma or tissue extracts into the
polycythemic mouse and measuring iron incorporation into red cells. In
vitro methods for EP measurements are available, but it is yet uncertain
that what they measure corresponds to erythropoietic potency. Solution of
this problem will be an important breakthrough.
Although the book is generally well written, its readability is occasionally
compromised by the authors' scholarly approach. All sides of every debate
are presented. A positive statement quoted from one publication is likely
to be qualified by a second and contradicted by a third. Paragraphs are
sometimes interrupted by several lines of reference numbers. (The last
100 pages of the volume are devoted to the reference list.) The scholarly
fair play and footnoting will assist EP researchers but may prove tedious
to those with a lesser commitment to this field. There are no tables or
figures, but there is an index which seems excellent.
PETER MC PHEDRAN
THE BIOCHEMICAL BASIS OF NEUROPHARMACOLOGY. By Jack Cooper,
Floyd E. Bloom, and Robert H. Roth. New York, Oxford University
Press, 1970. viii, 220 pp. $6.95.
This relatively brief monograph consists of an introduction and ten chap-
ters, each of which could be a well organized lecture on the topic it dis-
cusses. The rationale for the approach to the book, with its basic orienta-
tion towards neurotransmitters, is presented in the introduction. The
anatomical and physiological foundation are the subjects of the second
chapter and the biochemical approaches are outlined in the third chapter.
The next five chapters deal with specific putative transmitters-acetylcho-
line, catecholamines, serotonin, amino acids (a-amino butyric acid, glycine,
and glutamic acid) and others (histamine, prostoglandin, substance-P,
etc.), while the final chapter is devoted to cellular mechanisms in memory
and learning.
232OOK REVIEWS
The authors state in the introduction that their objective is to treat
what they think are the important aspects of neuropharmacology and to
present an integrated view of the multidisciplinary aspects relevant to the
development of this rapidly advancing field. They have accomplished their
objective admirably. The book is easily readable, the material well-
digested and integrated, the illustrations appropriate and clear, and the
distribution of space devoted to each topic is consistent with current
knowledge. This volume could provide an excellent lecture outline for a
portion of a neuropharmacology course and appears to have its origin in
such a course.
The references cited are mainly other reviews which can serve as
sources for further information. This book is an excellent introduction
for students interested in neuropharmacology and can be highly recom-
mended for medical students, psychiatrists and neurologists who wish to
become familiar with biological advances in neuropharmacology as well as
for graduate students entering this area of research.
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THE PHARMACOLOGICAL BASIS OF THERAPEUTICS. Fourth Edition. Edited
by Louis S. Goodman and Alfred Gilman. New York, The MacMillan
Company, 1970. xx, 1794 pp. $25.00.
Of the many textbooks used in the preclinical medical curriculum few have
the sustained value of this comprehensive text on Pharmacology. The Fourth
Edition continues the tradition of excellence of previous years. This is not
the superficial evaluation by one person of 1794 pages, richly packed with
detailed information and subtle interpretations. Rather, it is based on the
composite experience of the Faculty of the Department of Pharmacology at
Yale University. Many chapters have been rewritten in significant detail
and have been critically examined by each of us in the preparation of our
course lectures and, with perhaps equal frequency, as a source of pharma-
cological reference in areas related to our fields of investigation. These
comments should not be taken to indicate that this book is primarily de-
signed for the medical student and researcher. The hallmark of the First
Edition written in 1941, was its excellent organization. The physician faced
with a therapeutic problem can rapidly extract essential information and,
if necessary, return for a more comprehensive background of the physio-
logical, biochemical or toxicological details.
The introduction of multiple authorship in the Third Edition, an ar-
rangement essential to the scope of material covered, is continued. Despite
this, a remarkable consistency of style and presentation is to be found. The
chapters which introduce each section of the book provide excellent current
reviews of the physiological and biochemical principles of therapy. Docu-
mentation of the basic and applied aspects of therapeutics is unexcelled in
any currently available textbook. Although in every chapter both original
and review articles are quoted for 1968 and 1969, some may feel this renders
certain sections out of date in areas in which progress is rapid. In a meas-
ure this problem is solved by frequent references to agents that are still in
the investigational stage; nevertheless the obligation of the teacher, student
or physician to consult current sources for new drug information remains.
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